Candela Corporation, founded in 1970 and headquartered in Wayland, Massachusetts, USA, is a global leader in medical aesthetic device manufacturing, wholly-owned by Apax Partners. The company specializes in developing, manufacturing, and commercializing energy-based systems that include lasers, intense pulsed light (IPL), radiofrequency (RF), and ultrasound technologies. Its premier product lines are the Gentle Family (GentleLase, GentleMax Pro, GentleYag), Vbeam pulsed dye laser, Fraxel fractional laser, and elōs (electro-optical synergy) platforms. These devices address a wide range of aesthetic indications such as hair removal, skin rejuvenation, vascular and pigmented lesions, acne scars, and body contouring. Candela is renowned for its commitment to science, rigorous clinical evidence, and unmatched reliability, building deep trust with practitioners worldwide. With a commercial presence in over 70 countries, the company supports an extensive global network of physicians and medical aesthetic professionals. Heavy investments in R&D and strict product testing protocols ensure the highest levels of efficacy, safety, and compliance. Candela holds a leading market share in the global aesthetic laser segment, competing closely with Cynosure and Lumenis. Through continuous innovation and customer-centric design, the company empowers practitioners to deliver optimal patient outcomes. Its promise to ensure science, results, and trust has made Candela a cornerstone in the energy-based device industry.